The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France

Archive ouverte

Dimeglio, Chloé | Loubes, Jean-Michel | Deporte, Benjamin | Dubois, Martine | Latour, Justine | Mansuy, Jean-Michel | Izopet, Jacques

Edité par CCSD ; Elsevier -

International audience. A new virus, SARS-CoV-2, has spread world-wide since December 2019, probably affecting millions of people and killing thousands. Failure to anticipate the spread of the virus now seriously threatens many health systems. We have designed a model for predicting the evolution of the SARS-CoV-2 epidemic in France, which is based on seroprevalence and makes it possible to anticipate the deconfinement strategy

Consulter en ligne

Suggestions

Du même auteur

Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2

Archive ouverte | Dimeglio, Chloé | CCSD

International audience. The spread of SARS-CoV-2 and the resulting disease COVID-19 has killed over 2.6 million people as of 18 March 2021. We have used a modified susceptible, infected, recovered (SIR) epidemiologi...

Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants

Archive ouverte | Dimeglio, Chloé | CCSD

International audience. The B.1.1.529 SARS-CoV-2 lineage, named Omicron, was recently divided into three lineages (BA.1, BA.2 and BA.3). BA.1 and BA.2 are much more dominant than BA.3. BA.1 could cause breakthrough ...

Influence of Nasopharyngeal Viral Load on the Spread of the Omicron BA.2 Variant

Archive ouverte | Migueres, Marion | CCSD

International audience. We used variant typing polymerase chain reaction to describe the evolution of severe acute respiratory syndrome coronavirus 2 Omicron sublineages between December 2021 and mid-March 2022. The...

Chargement des enrichissements...